InvestorsHub on MSN
20/20 BioLabs licenses kidney disease prediction technology from ROKIT Healthcare
BioLabs, Inc. (NASDAQ:AIDX) announced it has signed an exclusive U.S. technology licensing and access agreement with ROKIT ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results